Vanguard Group’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$256K Hold
673,090
﹤0.01% 4044
2025
Q1
$700K Buy
673,090
+82,320
+14% +$85.6K ﹤0.01% 3809
2024
Q4
$577K Hold
590,770
﹤0.01% 3908
2024
Q3
$868K Hold
590,770
﹤0.01% 3817
2024
Q2
$798K Buy
590,770
+33,417
+6% +$45.1K ﹤0.01% 3869
2024
Q1
$914K Sell
557,353
-4,249
-0.8% -$6.97K ﹤0.01% 3845
2023
Q4
$1.08M Hold
561,602
﹤0.01% 3800
2023
Q3
$1.35M Sell
561,602
-1,356
-0.2% -$3.25K ﹤0.01% 3730
2023
Q2
$1.44M Buy
562,958
+39,034
+7% +$99.5K ﹤0.01% 3779
2023
Q1
$854K Buy
523,924
+80,100
+18% +$131K ﹤0.01% 3972
2022
Q4
$1.22M Buy
443,824
+98
+0% +$269 ﹤0.01% 3844
2022
Q3
$1.75M Buy
443,726
+315,559
+246% +$1.25M ﹤0.01% 3796
2022
Q2
$723K Buy
128,167
+15,647
+14% +$88.3K ﹤0.01% 4186
2022
Q1
$1.26M Sell
112,520
-65,361
-37% -$732K ﹤0.01% 4141
2021
Q4
$2.6M Buy
177,881
+36,943
+26% +$539K ﹤0.01% 3946
2021
Q3
$4.23M Sell
140,938
-855
-0.6% -$25.6K ﹤0.01% 3765
2021
Q2
$6.58M Sell
141,793
-16,510
-10% -$766K ﹤0.01% 3438
2021
Q1
$9.5M Buy
158,303
+1,054
+0.7% +$63.2K ﹤0.01% 3170
2020
Q4
$8.24M Sell
157,249
-3,720
-2% -$195K ﹤0.01% 3092
2020
Q3
$5.57M Buy
160,969
+16,569
+11% +$573K ﹤0.01% 3100
2020
Q2
$12.5M Buy
144,400
+31,440
+28% +$2.73M ﹤0.01% 2653
2020
Q1
$6.55M Buy
112,960
+13,079
+13% +$759K ﹤0.01% 2826
2019
Q4
$7.2M Buy
99,881
+377
+0.4% +$27.2K ﹤0.01% 3014
2019
Q3
$6.07M Buy
99,504
+34,784
+54% +$2.12M ﹤0.01% 3063
2019
Q2
$6.15M Sell
64,720
-12,631
-16% -$1.2M ﹤0.01% 3093
2019
Q1
$6.27M Buy
77,351
+4,999
+7% +$405K ﹤0.01% 3055
2018
Q4
$11.8M Buy
72,352
+49,781
+221% +$8.09M ﹤0.01% 2690
2018
Q3
$3.68M Buy
22,571
+11,318
+101% +$1.84M ﹤0.01% 3336
2018
Q2
$1.7M Buy
+11,253
New +$1.7M ﹤0.01% 3549